None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged =19 years. (2) Individuals who fall under any of the following indications for latent tuberculosis infection (LTBI) testing. Contacts of patients with infectious tuberculosis People living with HIV Persons currently receiving, or scheduled to receive, immunosuppressive agents Patients scheduled for treatment with TNF antagonists, other biologic agents, or small-molecule inhibitors Individuals with spontaneously healed tuberculosis lesions on chest radiography Persons currently using, or scheduled to use, long-term systemic corticosteroids Patients with autoimmune diseases Patients with chronic kidney disease, including those on dialysis Patients with hematologic malignancies or solid tumors Patients with diabetes mellitus Individuals who have undergone, or are scheduled to undergo, gastrectomy Patients with chronic lung disease (e.g., COPD, asthma, occupational/environmental lung diseases) Individuals with infection documented within the past two years (i.e., documented conversion on LTBI testing) Healthcare workers Employees of congregate settings with high transmission risk and public impact under the Tuberculosis Prevention Act (e.g., healthcare facilities, schools) Persons deemed by the local government, under the Act, to require LTBI screening due to high TB risk (e.g., vagrants, people experiencing homelessness) (3) Individuals who understand the study procedures, voluntarily agree to participate, and sign a written informed consent form in advance.
Exclusion criteria
Exclusion criteria: (1) Aged =18 years. (2) History of prior tuberculosis treatment. (3) Any individual whom the principal investigator deems unsuitable for this clinical study for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events occurring during latent tuberculosis infection treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Completion of latent tuberculosis infection (LTBI) treatment;Incident active tuberculosis | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital